(0350000132) HYDROXYTYROSOL AND COVID-19 (Q4129277): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item)
(‎Added qualifier: readability score (P590521): 0.0028688608291841)
 
(2 intermediate revisions by 2 users not shown)
Property / summary: (0350000132) HYDROXYTYROSOL AND COVID-19 (English) / qualifier
 
readability score: 0.0028688608291841
Amount0.0028688608291841
Unit1
Property / contained in Local Administrative Unit
 
Property / contained in Local Administrative Unit: Torino / rank
 
Normal rank
Property / Call for proposal
 
Property / Call for proposal: 14-20 V IR  Voucher alle imprese per l acquisizione di servizi qualificati e specialistici per la ricerca e innovazione presso Infrastrutture di Ricerca pubbliche e private (IR) / rank
 
Normal rank

Latest revision as of 10:14, 7 March 2024

Project Q4129277 in Italy
Language Label Description Also known as
English
(0350000132) HYDROXYTYROSOL AND COVID-19
Project Q4129277 in Italy

    Statements

    0 references
    10,500.0 Euro
    0 references
    21,000.0 Euro
    0 references
    50.0 percent
    0 references
    1 March 2021
    0 references
    14 April 2022
    0 references
    P&P FARMA SRL
    0 references
    0 references
    0 references

    45°4'3.94"N, 7°40'56.96"E
    0 references
    (0350000132) IDROSSITIROSOLO E COVID-19 (Italian)
    0 references
    (0350000132) HIDROXITIROSOL Y COVID-19 (Spanish)
    30 January 2022
    0 references
    (0350000132) HYDROXYTYROSOL AND COVID-19 (English)
    31 January 2022
    0.0028688608291841
    0 references
    (0350000132) HYDROXYTYROSOL ET COVID-19 (French)
    1 February 2022
    0 references
    (0350000132) HYDROXYTYROSOL UND COVID-19 (German)
    3 February 2022
    0 references
    (0350000132) HYDROXYTYROSOL EN COVID-19 (Dutch)
    3 February 2022
    0 references
    (0350000132) HYDROXYTYROSOL OG COVID-19 (Danish)
    20 July 2022
    0 references
    (0350000132) ΥΔΡΟΞΥΤΥΡΟΣΌΛΗ ΚΑΙ COVID-19 (Greek)
    20 July 2022
    0 references
    (0350000132) HIDROKSITIROSOL I COVID-19 (Croatian)
    20 July 2022
    0 references
    (0350000132) HIDROXITIROZOL ȘI COVID-19 (Romanian)
    20 July 2022
    0 references
    (0350000132) HYDROXYTYROZOL A COVID-19 (Slovak)
    20 July 2022
    0 references
    (0350000132) IDROSSITIROSOL U COVID-19 (Maltese)
    20 July 2022
    0 references
    (0350000132) HIDROXITIROSOL E COVID-19 (Portuguese)
    20 July 2022
    0 references
    (0350000132) HYDROKSITYROSOLI JA COVID-19 (Finnish)
    20 July 2022
    0 references
    (0350000132) HYDROKSYTYROZOL I COVID-19 (Polish)
    20 July 2022
    0 references
    (0350000132) HIDROKSITIROZOL IN COVID-19 (Slovenian)
    20 July 2022
    0 references
    (0350000132) HYDROXYTYROSOL A COVID-19 (Czech)
    20 July 2022
    0 references
    (0350000132) HIDROKSITIROZOLIS IR COVID-19 (Lithuanian)
    20 July 2022
    0 references
    (0350000132) HIDROKSITIROZOLS UN COVID-19 (Latvian)
    20 July 2022
    0 references
    (0350000132) ХИДРОКСИТИРОЗОЛ И COVID-19 (Bulgarian)
    20 July 2022
    0 references
    (0350000132) HIDROXITIROZOL ÉS COVID19 (Hungarian)
    20 July 2022
    0 references
    (0350000132) HIODROCSAITIREASÓL AGUS COVID-19 (Irish)
    20 July 2022
    0 references
    (0350000132) HYDROXITYROSOL OCH COVID-19 (Swedish)
    20 July 2022
    0 references
    (0350000132) HÜDROKSÜTÜROSOOL JA COVID-19 (Estonian)
    20 July 2022
    0 references
    TORINO
    0 references
    8 April 2023
    0 references

    Identifiers